The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Impact of the motor complications of Parkinson's disease on the quality of life
Abstract
The impact of motor complications of Parkinson's disease (PD), especially levodopa‐induced dyskinesias, on quality of life (QL) was studied in 143 patients with PD. All were evaluated on the Hoehn and Yahr (H&Y) scale, and the Motor part of the Unified Parkinson's Disease Rating Scale (UPDRS). Motor complications were analyzed using the UPDRS Parts IV A and IV B and the Abnormal Involuntary Movement Scale. A specific Parkinson's disease quality of life questionnaire (39‐item version, PDQ‐39) was used. Motor complications significantly worsened the PDQ‐39 Summary Index (PDQ‐SI) of patients with PD. The dimensions of Mobility, Activities of Daily Living, Stigma, and Communication were the most strongly affected. “Peak dose” dyskinesia decreased Mobility, Emotional Well‐Being, and Cognition, whereas biphasic dyskinesia affected Mobility, Stigma, Communication, and Activities of Daily Living. Morning akinesia, end‐of‐dose fluctuations, and “unpredictable offs” decreased QL on the dimensions of Mobility, Activities of Daily Living, Stigma, and Communication. Nocturnal akinesia led to a deterioration of all dimensions of the PDQ‐39. Thus, motor complications and especially nocturnal akinesia and biphasic dyskinesias worsened the QL of PD patients. © 2004 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
An Approximate Distribution of Estimates of Variance Components
Satterthwaite, F. E. (1946) · Biometrics Bulletin · doi:10.2307/3002019 · Cited by 4,373
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995) · Quality of Life Research · doi:10.1007/bf02260863 · Cited by 1,204
Schrag, A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.67 · Cited by 327
Cited by
Quality of life in Parkinson's disease: the relative importance of the symptoms
Rahman, S., Griffin, H. J., Quinn, N. P., & Jahanshahi, M. (2008) · Movement Disorders · doi:10.1002/mds.21667 · Cited by 532
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
Qian, Y., Yang, X., Xu, S., Wu, C., Song, Y., Qin, N., Chen, S.-D., & Xiao, Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.016 · Cited by 409
Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?
Hinnell, C., Hurt, C. S., Landau, S., Brown, R. G., Samuel, M., & on behalf of the PROMS‐PD Study Group (2012) · Movement Disorders · doi:10.1002/mds.23961 · Cited by 142
Gut Metagenomics-Derived Genes as Potential Biomarkers of Parkinson’s Disease
Qian, Y., Yang, X., Xu, S., Huang, P., Li, B., Du, J., He, Y., Su, B., Xu, L.-M., Wang, L., et al. (2020) · Brain · doi:10.1093/brain/awaa201 · Cited by 139
Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features
Ray Chaudhuri, K., Poewe, W., & Brooks, D. (2018) · Movement Disorders · doi:10.1002/mds.27386 · Cited by 121
Clinical implications of gastric complications on levodopa treatment in Parkinson’s disease
Pfeiffer, R. F., Isaacson, S. H., & Pahwa, R. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.05.001 · Cited by 77
Mera, T. O., Burack, M. A., & Giuffrida, J. P. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-120166 · Cited by 66
“Mobility [8], activities of daily living [8, 9], and communication [8, 9] are also affected.”
A Review on Wearable Technologies for Tremor Suppression
Lora-Millan, J. S., Delgado-Oleas, G., Benito-León, J., & Rocon, E. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.700600 · Cited by 62
“Almost a quarter of patients who go to treatment centers are forced to quit their profession, and 60% decide not to apply for jobs or promotions because of disabling symptoms (23).”
BackgroundSimpson, J., McMillan, H., & Reeve, D. (2013) · Parkinson's Disease · doi:10.1155/2013/608562 · Cited by 56
Prospective study on cost-effectiveness of home-based motor assessment in Parkinson’s disease
Cubo, E., Mariscal, N., Solano, B., Becerra, V, Armesto, D., Calvo, S., Arribas, J., Seco, J., Martinez, A., Zorrilla, L., et al. (2017) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x16638971 · Cited by 45
Thorley, E. M., Iyer, R. G., Wicks, P., Curran, C., Gandhi, S. K., Abler, V., Anderson, K. E., & Carlozzi, N. E. (2018) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-018-0312-x · Cited by 32
Metadata
- Authors
- Chapuis, S., Ouchchane, L., Metz, O., Gerbaud, L., & Durif, F.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2004-08-31
- Volume
- 20
- Issue
- 2
- Pages
- 224-230
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2078208735
- Cited by
- 521
- References
- 8
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
